Larson Financial Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $26.2M | Buy |
21,831
+4,817
| +28% | +$4.92M | 0.69% | 33 |
|
|
2026
Q1 | $15.6M | Buy |
17,014
+3,008
| +21% | +$3.05M | 0.5% | 41 |
|
|
2025
Q4 | $15.1M | Sell |
14,006
-2,755
| -16% | -$2.63M | 0.5% | 42 |
|
|
2025
Q3 | $12.8M | Buy |
16,761
+243
| +1% | +$181K | 0.45% | 50 |
|
|
2025
Q2 | $12.9M | Buy |
16,518
+335
| +2% | +$260K | 0.52% | 43 |
|
|
2025
Q1 | $13.4M | Buy |
16,183
+828
| +5% | +$689K | 0.63% | 36 |
|
|
2024
Q4 | $11.9M | Buy |
15,355
+511
| +3% | +$423K | 0.61% | 34 |
|
|
2024
Q3 | $13.2M | Sell |
14,844
-300
| -2% | -$270K | 0.75% | 29 |
|
|
2024
Q2 | $13.7M | Buy |
15,144
+5,761
| +61% | +$4.61M | 0.93% | 24 |
|
|
2024
Q1 | $7.3M | Buy |
9,383
+170
| +2% | +$121K | 0.56% | 40 |
|
|
2023
Q4 | $5.37M | Buy |
9,213
+266
| +3% | +$155K | 0.47% | 43 |
|
|
2023
Q3 | $4.81M | Buy |
8,947
+5,027
| +128% | +$2.59M | 0.47% | 47 |
|
|
2023
Q2 | $1.84M | Sell |
3,920
-162
| -4% | -$67.9K | 0.18% | 101 |
|
|
2023
Q1 | $1.4M | Buy |
4,082
+99
| +2% | +$33.4K | 0.15% | 131 |
|
|
2022
Q4 | $1.46M | Buy |
3,983
+2
| +0.1% | +$709 | 0.17% | 118 |
|
|
2022
Q3 | $1.29M | Buy |
3,981
+186
| +5% | +$58.9K | 0.18% | 112 |
|
|
2022
Q2 | $1.23M | Buy |
3,795
+747
| +25% | +$224K | 0.21% | 57 |
|
|
2022
Q1 | $873K | Buy |
3,048
+69
| +2% | +$17.8K | 0.14% | 78 |
|
|
2021
Q4 | $823K | Buy |
2,979
+1,582
| +113% | +$401K | 0.13% | 79 |
|
|
2021
Q3 | $323K | Sell |
1,397
-198
| -12% | -$48.9K | 0.06% | 108 |
|
|
2021
Q2 | $366K | Buy |
1,595
+2
| +0.1% | +$402 | 0.09% | 90 |
|
|
2021
Q1 | $298K | Buy |
1,593
+546
| +52% | +$107K | 0.09% | 86 |
|
|
2020
Q4 | $177K | Buy |
1,047
+1
| +0.1% | +$149 | 0.06% | 106 |
|
|
2020
Q3 | $155K | Hold |
1,046
| – | – | 0.06% | 102 |
|
|
2020
Q2 | $172K | Hold |
1,046
| – | – | 0.08% | 107 |
|
|
2020
Q1 | $145K | Hold |
1,046
| – | – | 0.09% | 89 |
|
|
2019
Q4 | $138K | Sell |
1,046
-161
| -13% | -$18.7K | 0.08% | 91 |
|
|
2019
Q3 | $135K | Buy |
1,207
+759
| +169% | +$84.5K | 0.09% | 94 |
|
|
2019
Q2 | $50K | Hold |
448
| – | – | 0.04% | 126 |
|
|
2019
Q1 | $58K | Buy |
448
+200
| +81% | +$24.3K | 0.05% | 106 |
|
|
2018
Q4 | $29K | Buy |
+248
| New | +$27.7K | 0.03% | 132 |
|
Other funds holding LLY
Larson Financial Group's LLY Position: Q2 2026 in Review
Larson Financial Group increased its Eli Lilly (LLY) stake by 28% in Q2 2026, buying an estimated $4.92M and bringing the position to 21,831 shares worth $26.2M. The position accounts for 0.69% of the portfolio, ranked #33.
Larson Financial Group first reported a position in LLY in Q4 2018 and has held it in 31 quarters since. 4,633 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Larson Financial Group held 21,831 shares of Eli Lilly worth $26.2M as of Q2 2026.
- Larson Financial Group bought 4,817 Eli Lilly shares in Q2 2026, an estimated $4.92M.
- Eli Lilly made up 0.69% of Larson Financial Group's portfolio in Q2 2026, its #33 holding.
- Larson Financial Group first reported a position in Eli Lilly in Q4 2018 and has held it in 31 quarters since.
- 4,633 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.